University of California, Irvine Medical Center
Orange, California, 92868, United States
NCT Number: NCT02326636
The purpose of this research is to investigate the efficacy of transplanting screened donor fecal material in treating patients with recurrent Clostridium difficile infection. Participants with refractory Clostridium difficile infection will be given healthy donor stool administered by colonoscopy or enema and their response will be evaluated by symptom questionnaire and stool testing for Clostridium difficile at 4 weeks after the treatment.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Observational
Orange, California, 92868, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for Recipient:
Examples of standard therapy are:
Exclusion criteria
for Recipient:
Participants with refractory Clostridium difficile infection will be given healthy donor stool administered by colonoscopy or enema.
Time frame: Four weeks
Time frame: Four weeks
Time frame: Up to 24 weeks
Subjects will complete a satisfaction questionnaire following the FMT procedure.
Time frame: Four weeks
Subjects will complete a quality of life questionnaire before and 4 weeks after FMT.
Time frame: Up to 24 weeks
Subjects medication and treatment history for Clostridium difficile before and after FMT will be collected.
Time frame: Up to 24 weeks
University of California, Irvine
Other
Acronym: FMT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03030248
Bacterial Infections, Bacterial Infections and Mycoses
Milwaukee, Wisconsin, United States
View Trial DetailsNCT04940468
Bacterial Infections, Bacterial Infections and Mycoses
Aurora, Colorado, United States
View Trial DetailsNCT04090346
Bacterial Infections, Bacterial Infections and Mycoses
Dallas, Texas, United States
View Trial DetailsNCT04138706
Bacterial Infections, Bacterial Infections and Mycoses
Vancouver, British Columbia, Canada
View Trial Details